Home › Funds › Manatuck Hill Partners, LLC › ANGO

Manatuck Hill Partners, LLC position in ANGO

ANGIODYNAMICS INC · Health Care

Manatuck Hill Partners, LLC reported holding 218,200 shares of ANGO (ANGIODYNAMICS INC) in its Q3 2026 13F filing — a position valued at US$3.4M, representing 1.14% of its reported portfolio and ranking #24 among its reported holdings. Manatuck Hill Partners, LLC has disclosed ANGO holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)218.20K sh
Reported value held$3.36M
Portfolio Weight1.14%
First reportedQ2 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Manatuck Hill Partners, LLC's ANGO position evolved

Manatuck Hill Partners, LLC first disclosed a stake in ANGO in Q2 2024 at 50,000 shares (US$302K). The position peaked in Q4 2025 at 425,000 shares, worth US$5.5M. Across 10 filings, Manatuck Hill Partners, LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 218,200 shares valued at US$3.4M — a reduction of -58,300 shares quarter over quarter.. Notable position changes include a 50% increase in Q3 2024 (shares rose 18% over the following quarter), a 166% increase in Q4 2024 (shares rose 3% over the following quarter), a 63% increase in Q1 2025 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 50.00K $302.50K New
Q3 2024 75.00K $583.50K Add
Q4 2024 199.50K $1.83M Add
Q1 2025 325.00K $3.05M Add
Q2 2025 350.00K $3.47M Add
Q3 2025 400.00K $4.47M Add
Q4 2025 425.00K $5.46M Add
Q1 2026 475.00K $5.40M Add
Q2 2026 276.50K $3.60M Reduce
Q3 2026 218.20K $3.36M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANGO and 13F data

ANGO (ANGIODYNAMICS INC) is a Health Care company. 28 other funds we track also report a position in ANGO — the largest reported positions include SYSTEMATIC FINANCIAL MANAGEMENT LP (US$40.1M), Broadfin Holdings LLC (US$27.1M), ARMISTICE CAPITAL, LLC (US$23.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANGO

All ANGO fund holders →

FAQ

How long has Manatuck Hill Partners, LLC held ANGO?

Manatuck Hill Partners, LLC has disclosed ANGO holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Manatuck Hill Partners, LLC's current position in ANGO?

As of Q3 2026, Manatuck Hill Partners, LLC holds 218.20K shares of ANGO (ANGIODYNAMICS INC), valued at $3.36M, representing 1.14% of its reported portfolio and ranking #24.

Has Manatuck Hill Partners, LLC been buying or selling ANGO?

In the latest 13F filing (Q3 2026), Manatuck Hill Partners, LLC reduced its position in ANGO. The position peaked in Q4 2025 at 425.00K shares.

Which other funds hold ANGO?

Other major institutional holders of ANGO include SYSTEMATIC FINANCIAL MANAGEMENT LP, Broadfin Holdings LLC, ARMISTICE CAPITAL, LLC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.